How great is the risk of abuse in infants born to drug-using mothers?

K Street1, J Harrington, W Chiang

  • 1Centre for Child and Adolescent Health, Hampton House, Cotham Hill, Bristol, UK. Karen_street_khan@yahoo.co.uk

Insights

Maternal drug use in the UK does not automatically mean poor parenting. While initial concerns may arise, most children of drug-using mothers do not face long-term child protection issues.

Area of Science:

  • Public Health
  • Child Development
  • Maternal Health

Background:

  • Maternal drug use is linked to child abuse in North America.
  • UK data on this association is lacking.
  • Drug cultures vary, making US data generalization difficult.

Purpose of the Study:

  • To investigate child protection and surveillance markers for UK infants born to self-proclaimed drug-using mothers.
  • To compare these markers with infants of non-drug users.

Main Methods:

  • Prospective cohort study of pregnant drug users and matched non-drug users.
  • Involved antenatal clinic referrals and hospital-based data.
  • Child protection registers and health surveillance records were reviewed at 18 months.

Main Results:

  • No significant difference in child protection proceedings between groups initially.
  • Higher overall risk for children of drug users, but largely due to temporary care or short-lived concerns.
  • Child health surveillance uptake was lower in both groups.

Conclusions:

  • Maternal drug use does not inherently result in poor parenting standards.
  • Further UK-specific research is required for accurate child protection risk assessment.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...